Medirom CFO reports 40,000-share insider stake

Medirom Healthcare Technologies Inc. filed an initial ownership report for Chief Financial Officer and director Fujiwara Fumitoshi.

Accepted by SEC EDGAR 03/18/2026 - 01:23 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medirom Healthcare Technologies Inc. filed an initial ownership report for Chief Financial Officer and director Fujiwara Fumitoshi. The filing shows direct beneficial ownership of 40,000 Common Shares following the reported position. This Form 3 does not reflect any new purchase or sale transactions, only the existing holdings.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Fujiwara Fumitoshi

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Holding	Common Shares	--	--	--

Holdings: Common Shares — 40,000 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Medirom (MRM) disclose in this Form 3 filing?

The Form 3 discloses that CFO and director Fujiwara Fumitoshi beneficially owns 40,000 Common Shares of Medirom Healthcare Technologies Inc. It is an initial ownership report, showing existing holdings rather than new buy or sell transactions.

How many Medirom (MRM) shares does Fujiwara Fumitoshi hold?

Fujiwara Fumitoshi is reported as directly owning 40,000 Common Shares of Medirom Healthcare Technologies Inc. This figure represents his beneficial ownership following the reported position in the Form 3 and is not tied to a specific trade.

Is there any buying or selling of Medirom (MRM) shares in this Form 3?

No, the Form 3 does not show any buying or selling activity. It only records Fujiwara Fumitoshi’s existing direct beneficial ownership of 40,000 Common Shares, serving as a baseline disclosure of his stake as an insider.

What role does Fujiwara Fumitoshi have at Medirom (MRM)?

Fujiwara Fumitoshi is identified as both a director and an officer of Medirom Healthcare Technologies Inc., serving as Chief Financial Officer. The Form 3 links his executive and board roles to his reported ownership of 40,000 Common Shares.

Are the Medirom (MRM) shares held directly or indirectly by Fujiwara Fumitoshi?

The Form 3 shows the 40,000 Common Shares are held with direct ownership. The ownership code is listed as “D,” indicating direct beneficial ownership rather than holdings through a trust, partnership, or other indirect entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fujiwara Fumitoshi

(Last) (First) (Middle)

2-3-1 DAIBA

(Street)

MINATO-KU 135-0091

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Medirom Healthcare Technologies Inc. [ MRM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	40,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)